Abstract
A large scale multicenter randomized controlled study was conducted to evaluate the efficacy of intravenous immunoglobulin in combination with IPM/CS and AMK in 504 evaluable patients who did not respond by 3 day therapy with beta-lactum and aminoglucoside. Immunoglobulin 5 g was administered 3 days to the patients allocated to immunoglobulin group. A completely automatic computer evaluation was performed according to the criteria determined by the committee. The response rate was 61.5% in immunoglobulin group and 47.3% in control group(p < 0.001). Intravenous immunoglobulin is considered effective for severe infection when used as combination therapy with antibiotics.
Publication types
-
Clinical Trial
-
English Abstract
-
Randomized Controlled Trial
MeSH terms
-
Amikacin / administration & dosage*
-
Anti-Bacterial Agents / administration & dosage*
-
Bacterial Infections / drug therapy
-
Cilastatin / administration & dosage*
-
Drug Therapy, Combination / administration & dosage*
-
Humans
-
Imipenem / administration & dosage*
-
Immunoglobulins, Intravenous / administration & dosage*
-
Multicenter Studies as Topic
-
Protease Inhibitors / administration & dosage*
-
Randomized Controlled Trials as Topic
-
Thienamycins / administration & dosage*
Substances
-
Anti-Bacterial Agents
-
Immunoglobulins, Intravenous
-
Protease Inhibitors
-
Thienamycins
-
Cilastatin
-
Imipenem
-
Amikacin